On September 1, 2026 INOVIO (NASDAQ:INO), a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from HPV-related diseases, cancer and infectious diseases, reported that it will participate in the following investor conferences:
Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:
Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing
Schedule Your 30 min Free Demo!
Cantor Global Healthcare Conference (New York)
Date: Wednesday, September 9
Fireside Chat: 3:20 PM ET
Webcast: View Source;eventId=99315971&checkCompany=1&checkEmail=1&checkName=1
H.C. Wainwright 28th Annual Global Investment Conference (New York)
Presentation Available: Beginning Friday, September 11, 7:00 AM ET
Format: Virtual
Link: View Source
Replays of the investor presentations will be available for 90 days at the links above. During these conferences members of INOVIO’s management team will also be conducting one-on-one meetings with investors.
(Press release, Inovio, SEP 1, 2026, View Source [SID1234670488])